康隆生物 (872213.OC)

+ 收藏

利润表(康隆生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 63,383,902.79141,689,680.9775,615,125.88119,232,298.9056,424,944.91
 营业收入(元) 63,383,902.79141,689,680.9775,615,125.88119,232,298.9056,424,944.91
二、营业总成本(元) 58,952,763.48127,209,907.6064,930,757.35106,613,422.6950,968,763.42
 营业成本(元) 45,135,204.12101,685,719.0054,357,476.8489,711,991.7643,439,085.25
 研发费用(元) 2,123,538.734,076,565.55809,748.961,863,385.60829,651.51
 营业税金及附加(元) 629,536.25722,968.42531,852.08652,346.16331,135.21
 销售费用(元) 9,549,540.7214,943,084.656,698,599.3912,234,325.115,627,719.42
 管理费用(元) 1,841,993.665,460,941.542,114,791.083,243,810.401,302,081.48
 财务费用(元) -327,050.00320,628.44418,289.00-1,092,436.34-560,909.45
  其中:利息费用(元) 531,698.60820,742.80378,563.82650,188.73296,709.73
  其中:利息收入(元) 11,964.9617,663.568,623.1935,115.188,640.76
三、其他经营收益
 资产减值损失(元) 54,412.03-96,545.32--28,219.38-54,635.82
 信用减值损失(元) -1,110.05-612,600.88-385,121.53-128,572.47-380,828.73
 其他收益(元) 527,300.00487,376.65494,097.08479,341.91184,839.91
四、营业利润(元) 5,011,741.2914,258,003.8210,793,344.0812,941,426.275,205,556.85
 加:营业外收入(元) 6,276.49625,468.656,214.13534,489.833,805.85
 减:营业外支出(元) 1,971.042,978.162,896.6978,282.0352,203.27
五、利润总额(元) 5,016,046.7414,880,494.3110,796,661.5213,397,634.075,157,159.43
 减:所得税费用(元) 548,233.902,783,172.871,195,672.732,159,489.191,031,729.15
六、净利润(元) 4,467,812.8412,097,321.449,600,988.7911,238,144.884,125,430.28
(一)按经营持续性分类
  持续经营净利润(元) 4,467,812.8412,097,321.449,600,988.7911,238,144.884,125,430.28
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 4,467,812.8412,097,321.449,600,988.7911,238,144.884,125,430.28
 扣除非经常性损益后的净利润(元) 4,320,512.8411,175,564.509,524,686.6910,528,441.964,006,582.83
七、每股收益
 一、基本每股收益(元) 0.150.620.490.570.21
 二、稀释每股收益(元) 0.150.620.490.570.21
八、其他综合收益(元) 766.40-55,035.09--326,734.81-
 归属于母公司股东的其他综合收益(元) 766.40-55,035.09--326,734.81-
九、综合收益总额(元) 4,468,579.2412,042,286.359,600,988.7910,911,410.074,125,430.28
 归属于母公司所有者的综合收益总额(元) 4,468,579.2412,042,286.359,600,988.7910,911,410.074,125,430.28
公告日期 2024-08-272024-04-292023-08-292023-04-272022-08-29
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院